⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 222 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$2.3T
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 1/3 (Toplam: 222)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $722.35B | $762.18 | 1.23% |
| ABT | Abbott Laboratories | $216.47B | $124.42 | 0.61% |
| BSX | Boston Scientific Corporation | $153.54B | $103.78 | 0.14% |
| TMO | Thermo Fisher Scientific Inc. | $152.86B | $404.94 | 2.37% |
| DHR | Danaher Corporation | $134.60B | $188.07 | 1.04% |
| VRTX | Vertex Pharmaceuticals Incorporated | $117.74B | $458.49 | 0.29% |
| MDT | Medtronic plc | $114.93B | $89.70 | 0.10% |
| ZTS | Zoetis Inc. | $65.61B | $147.37 | 0.83% |
| REGN | Regeneron Pharmaceuticals, Inc. | $57.91B | $545.53 | 0.55% |
| EW | Edwards Lifesciences Corporation | $44.91B | $76.56 | 0.09% |
| IDXX | IDEXX Laboratories, Inc. | $41.89B | $520.87 | 1.22% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $41.79B | $320.52 | 0.00% |
| GEHC | GE HealthCare Technologies Inc. | $33.96B | $74.16 | 2.37% |
| DXCM | DexCom, Inc. | $32.95B | $84.03 | 0.17% |
| LH | Laboratory Corporation of America Holdings | $20.33B | $243.04 | 0.28% |
| NTRA | Natera, Inc. | $19.20B | $140.63 | 1.25% |
| DGX | Quest Diagnostics Incorporated | $18.58B | $166.45 | 0.28% |
| ILMN | Illumina, Inc. | $15.01B | $94.80 | 1.40% |
| HOLX | Hologic, Inc. | $14.19B | $63.69 | 0.47% |
| SOLV | Solventum Corporation | $12.52B | $72.34 | 1.28% |
| EXEL | Exelixis, Inc. | $12.07B | $44.26 | 0.47% |
| DVA | DaVita Inc. | $10.53B | $139.43 | 1.23% |
| TEM | Tempus AI, Inc. | $9.75B | $58.01 | 4.87% |
| EXAS | Exact Sciences Corporation | $9.12B | $48.36 | 4.16% |
| MEDP | Medpace Holdings, Inc. | $8.88B | $308.88 | 0.96% |
| BBIO | BridgeBio Pharma, Inc. | $8.72B | $45.90 | 1.31% |
| AVTR | Avantor, Inc. | $8.41B | $12.34 | 7.15% |
| HSIC | Henry Schein, Inc. | $8.41B | $69.07 | 0.04% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| TECH | Bio-Techne Corporation | $7.88B | $50.27 | 3.36% |
| BIO | Bio-Rad Laboratories, Inc. | $6.65B | $244.25 | 0.87% |
| IONS | Ionis Pharmaceuticals, Inc. | $6.61B | $41.55 | 0.50% |
| CHE | Chemed Corporation | $6.57B | $449.42 | 0.42% |
| RGEN | Repligen Corporation | $6.45B | $114.80 | 1.25% |
| GH | Guardant Health, Inc. | $5.65B | $45.64 | 1.76% |
| BRKR | Bruker Corporation | $5.40B | $35.63 | 12.12% |
| LNTH | Lantheus Holdings, Inc. | $4.95B | $71.56 | 1.97% |
| RDNT | RadNet, Inc. | $4.35B | $57.94 | 0.78% |
| IRTC | iRhythm Technologies, Inc. | $4.33B | $135.52 | 0.53% |
| RNA | Avidity Biosciences, Inc. | $4.10B | $34.02 | 0.77% |
| ADMA | ADMA Biologics, Inc. | $4.09B | $17.13 | 2.39% |
| SRRK | Scholar Rock Holding Corporation | $3.90B | $41.12 | 0.98% |
| PTCT | PTC Therapeutics, Inc. | $3.79B | $47.86 | 0.48% |
| HAE | Haemonetics Corporation | $3.54B | $73.77 | 1.68% |
| NVST | Envista Holdings Corp | $3.30B | $19.47 | 0.20% |
| AMED | Amedisys, Inc. | $3.21B | $97.71 | 0.26% |
| KYMR | Kymera Therapeutics, Inc. | $3.17B | $45.14 | 2.25% |
| SHC | Sotera Health Company | $3.13B | $11.01 | 0.45% |
| RXRX | Recursion Pharmaceuticals, Inc. | $2.56B | $6.40 | 9.59% |
| CON | Concentra Group Holdings Parent, Inc. | $2.56B | $19.95 | 1.99% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.49B | $26.39 | 0.30% |
| APLS | Apellis Pharmaceuticals, Inc. | $2.42B | $19.28 | 0.98% |
| IBRX | ImmunityBio, Inc. | $2.37B | $2.68 | 2.55% |
| TWST | Twist Bioscience Corporation | $2.08B | $34.77 | 1.14% |
| CGON | CG Oncology, Inc. Common stock | $2.05B | $26.90 | 0.56% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $2.03B | $14.71 | 12.23% |
| DNLI | Denali Therapeutics Inc. | $2.01B | $13.83 | 1.21% |
| BLTE | Belite Bio, Inc | $1.99B | $61.30 | 0.62% |
| PGNY | Progyny, Inc. | $1.97B | $22.94 | 4.27% |
| IDYA | IDEAYA Biosciences, Inc. | $1.91B | $21.81 | 1.02% |
| FOLD | Amicus Therapeutics, Inc. | $1.86B | $6.05 | 1.51% |
| QDEL | QuidelOrtho Corporation | $1.71B | $25.30 | 0.59% |
| CERT | Certara, Inc. | $1.65B | $10.14 | 0.40% |
| ARDT | Ardent Health Partners, LLC | $1.57B | $10.95 | 1.44% |
| ADPT | Adaptive Biotechnologies Corporation | $1.57B | $10.31 | 0.77% |
| TDOC | Teladoc Health, Inc. | $1.46B | $8.33 | 3.48% |
| TXG | 10x Genomics, Inc. | $1.44B | $11.54 | 5.02% |
| AZTA | Azenta, Inc. | $1.43B | $31.32 | 0.51% |
| DVAX | Dynavax Technologies Corporation | $1.31B | $10.94 | 2.05% |
| GRAL | GRAIL, Inc. | $1.24B | $34.35 | 2.39% |
| NVAX | Novavax, Inc. | $1.16B | $7.17 | 2.43% |
| ASTH | Astrana Health, Inc. | $1.15B | $23.04 | 1.72% |
| PRAX | Praxis Precision Medicines, Inc. | $1.12B | $55.16 | 2.43% |
| OPK | OPKO Health, Inc. | $1.11B | $1.40 | 3.70% |
| MD | Pediatrix Medical Group, Inc. | $1.09B | $12.64 | 0.56% |
| NEOG | Neogen Corporation | $1.04B | $4.78 | 0.84% |
| RCUS | Arcus Biosciences, Inc. | $980.50M | $9.26 | 1.20% |
| PROK | ProKidney Corp. | $946.58M | $3.22 | 2.22% |
| IMNM | Immunome, Inc. | $941.47M | $10.82 | 2.27% |
| NRIX | Nurix Therapeutics, Inc. | $860.06M | $11.25 | 0.36% |
| KMTS | Kestra Medical Technologies, Ltd. Common Stock | $853.93M | $16.63 | 4.59% |
| NUVB | Nuvation Bio Inc. | $797.27M | $2.35 | 2.17% |
| GERN | Geron Corporation | $783.41M | $1.23 | 0.81% |
| TNGX | Tango Therapeutics, Inc. | $733.83M | $6.77 | 0.00% |
| CDNA | CareDx, Inc | $709.93M | $12.75 | 7.01% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $662.58M | $11.32 | 11.75% |
| GYRE | Gyre Therapeutics, Inc. | $641.30M | $7.10 | 1.53% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $637.47M | $2.38 | 2.06% |
| BBNX | Beta Bionics, Inc. | $619.99M | $14.30 | 5.22% |
| NUTX | Nutex Health, Inc. | $617.67M | $111.19 | 2.30% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $612.99M | $11.24 | 2.84% |
| ABUS | Arbutus Biopharma Corporation | $601.39M | $3.14 | 0.32% |
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| KURA | Kura Oncology, Inc. | $560.14M | $6.47 | 1.73% |
| KROS | Keros Therapeutics, Inc. | $560.09M | $13.79 | 0.29% |
| CBLL | CeriBell, Inc. | $549.74M | $15.21 | 2.37% |
| PSNL | Personalis, Inc. | $547.62M | $6.20 | 0.16% |
| FLGT | Fulgent Genetics, Inc. | $540.37M | $17.75 | 0.17% |
| AVNS | Avanos Medical, Inc. | $526.72M | $11.39 | 1.52% |
| SIGA | SIGA Technologies, Inc. | $489.37M | $6.85 | 3.63% |